Inhibikase Therapeutics, Inc. (IKT)

Every official Inhibikase Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Inhibikase Therapeutics, Inc. documents

• Inhibikase Therapeutics, Inc. 10-K 2026IKT 10-K 2026: annual report for fiscal 2026
• Inhibikase Therapeutics, Inc. 10-K 2025IKT 10-K 2025: annual report for fiscal 2025
• Inhibikase Therapeutics, Inc. 10-K 2024IKT 10-K 2024: annual report for fiscal 2024
• Inhibikase Therapeutics, Inc. 10-K 2023IKT 10-K 2023: annual report for fiscal 2023
• Inhibikase Therapeutics, Inc. 10-K 2022IKT 10-K 2022: annual report for fiscal 2022
• Inhibikase Therapeutics, Inc. 10-Q 2026IKT 10-Q 2026: quarterly report for fiscal 2026
• Inhibikase Therapeutics, Inc. 10-Q 2025IKT 10-Q 2025: quarterly report for fiscal 2025
• Inhibikase Therapeutics, Inc. 10-Q 2024IKT 10-Q 2024: quarterly report for fiscal 2024
• Inhibikase Therapeutics, Inc. 10-Q 2023IKT 10-Q 2023: quarterly report for fiscal 2023
• Inhibikase Therapeutics, Inc. 10-Q 2022IKT 10-Q 2022: quarterly report for fiscal 2022
• Inhibikase Therapeutics, Inc. 8-K 2026IKT 8-K 2026: current report for fiscal 2026
• Inhibikase Therapeutics, Inc. 8-K 2025IKT 8-K 2025: current report for fiscal 2025
• Inhibikase Therapeutics, Inc. 8-K 2024IKT 8-K 2024: current report for fiscal 2024
• Inhibikase Therapeutics, Inc. 8-K 2023IKT 8-K 2023: current report for fiscal 2023
• Inhibikase Therapeutics, Inc. 8-K 2022IKT 8-K 2022: current report for fiscal 2022
• Inhibikase Therapeutics, Inc. DEF 14A 2026IKT DEF 14A 2026: proxy statement for fiscal 2026
• Inhibikase Therapeutics, Inc. DEF 14A 2025IKT DEF 14A 2025: proxy statement for fiscal 2025
• Inhibikase Therapeutics, Inc. DEF 14A 2024IKT DEF 14A 2024: proxy statement for fiscal 2024
• Inhibikase Therapeutics, Inc. DEF 14A 2023IKT DEF 14A 2023: proxy statement for fiscal 2023
• Inhibikase Therapeutics, Inc. DEF 14A 2022IKT DEF 14A 2022: proxy statement for fiscal 2022
• Inhibikase Therapeutics, Inc. Form 4 2026IKT Form 4 2026: insider trading filing for fiscal 2026
• Inhibikase Therapeutics, Inc. Form 4 2025IKT Form 4 2025: insider trading filing for fiscal 2025
• Inhibikase Therapeutics, Inc. Form 4 2024IKT Form 4 2024: insider trading filing for fiscal 2024
• Inhibikase Therapeutics, Inc. Form 4 2023IKT Form 4 2023: insider trading filing for fiscal 2023
• Inhibikase Therapeutics, Inc. Form 4 2022IKT Form 4 2022: insider trading filing for fiscal 2022
• Inhibikase Therapeutics, Inc. S-1 2026IKT S-1 2026: registration statement for fiscal 2026
• Inhibikase Therapeutics, Inc. S-1 2025IKT S-1 2025: registration statement for fiscal 2025
• Inhibikase Therapeutics, Inc. S-1 2024IKT S-1 2024: registration statement for fiscal 2024
• Inhibikase Therapeutics, Inc. S-1 2023IKT S-1 2023: registration statement for fiscal 2023
• Inhibikase Therapeutics, Inc. S-1 2022IKT S-1 2022: registration statement for fiscal 2022
• Inhibikase Therapeutics, Inc. 13F 2026IKT 13F 2026: institutional holdings for fiscal 2026
• Inhibikase Therapeutics, Inc. 13F 2025IKT 13F 2025: institutional holdings for fiscal 2025
• Inhibikase Therapeutics, Inc. 13F 2024IKT 13F 2024: institutional holdings for fiscal 2024
• Inhibikase Therapeutics, Inc. 13F 2023IKT 13F 2023: institutional holdings for fiscal 2023
• Inhibikase Therapeutics, Inc. 13F 2022IKT 13F 2022: institutional holdings for fiscal 2022

More companies